Survival rates lower among African Americans with colon cancer
the ONA take:
African Americans with colon cancer have lower survival rates compared with white patients, despite an overall decline in colon cancer deaths.
However, delivering evidence-based care within an integrated health care system can improve survival rates for this population.
Investigators from the Stanford University School of Medicine evaluated the records of more than 30,000 patients with colon cancer who underwent treatment for their disease, comparing the care delivery with recommendations from the National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines in Oncology for Colon Cancer.
Their study results demonstrated that better overall survival rates were seen in all patients, including minorities, treated with integrated health systems—includes hospital-based care, outpatient services, and rehabilitation.
The investigators conclude that providing evidence-based care that follows the sequential management decisions outlined in the NCCN Guidelines can equalize racial disparities and improve care for all patients.
African Americans with colon cancer have lower survival rates compared with white patients.
Sign Up for Free e-newsletters
- FDA Issues Warning for Rolapitant Injectable Emulsion in the Treatment of CINV
- Risk Factors for Arterial, Venous Thrombosis Differ in Polycythemia Vera
- Resolving Vaginal Dryness in Women With a History of Breast Cancer
- BRCA Mutation Improves Prognosis for 2-year Survival in Younger-onset TNBC
- Identifying the Psychosocial Needs of Young Adults With Metastatic Cancer
- Pertuzumab Regimen Approved for Adjuvant, Neoadjuvant Therapy in Specific Breast Cancers
- Common Oncologic Emergencies That Occur With Multiple Myeloma
- Artificial Sweeteners and Cancer Risk (Fact Sheet)
- Blueberry Extract May Boost Efficacy of Radiotherapy for Cervical Cancer
- Dietary Estrogens Reduced Efficacy of Novel Breast Cancer Therapy
- Partial Response Achieved With Atezolizumab, Cobimetinib in Pretreated CRC
- Novel Approach Can Improve Both Colorectal Cancer Screening Outcomes and Adherence
- Survival Outcomes in Relapsed Hepatocellular Carcinoma Improved With Cabozantinib
- OS Similar With Gemcitabine Plus S-1 vs Standard Therapy for Biliary Tract Cancer
- Feasibility and Outcomes of Modified Enhanced Recovery After Surgery for Nursing Management of Aged Patients Undergoing Esophagectomy
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|